Certified by Founder Lodge
adMare BioInnovations
Canada - ND
INVESTOR
1 Disclosed Funding Rounds $142,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
With offices in Montreal, Vancouver and Toronto, adMare is building Canada’s life science industry from sea to sea. With a strong track record of globally-competitive scientific discovery, Ca
| Company | Date | Round | Raised |
|---|---|---|---|
 Abdera Therapeutics |
April, 24 ,2023 | Series B | $142,000,000 |
 Specific Biologics |
October, 17 ,2023 | Unknown |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Jupid | $840,000 | (May 1, 2026)
DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Illuminant Surgical | $8,400,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)
